WO2022121063A1 - Method for optimization of disease analysis and identification by multi-data correlation fusion of characterization, blood, and medical image data - Google Patents
Method for optimization of disease analysis and identification by multi-data correlation fusion of characterization, blood, and medical image data Download PDFInfo
- Publication number
- WO2022121063A1 WO2022121063A1 PCT/CN2021/000232 CN2021000232W WO2022121063A1 WO 2022121063 A1 WO2022121063 A1 WO 2022121063A1 CN 2021000232 W CN2021000232 W CN 2021000232W WO 2022121063 A1 WO2022121063 A1 WO 2022121063A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- feature
- disease
- data
- identification
- intelligent
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 60
- 201000010099 disease Diseases 0.000 title claims abstract description 50
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 50
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- 239000008280 blood Substances 0.000 title claims abstract description 25
- 238000005457 optimization Methods 0.000 title claims abstract description 19
- 238000004458 analytical method Methods 0.000 title claims abstract description 18
- 230000004927 fusion Effects 0.000 title claims abstract description 18
- 238000012512 characterization method Methods 0.000 title claims abstract description 11
- 230000002068 genetic effect Effects 0.000 claims abstract description 7
- 210000000056 organ Anatomy 0.000 claims description 60
- 230000002159 abnormal effect Effects 0.000 claims description 36
- 210000000601 blood cell Anatomy 0.000 claims description 12
- 210000000349 chromosome Anatomy 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 9
- 238000004364 calculation method Methods 0.000 claims description 8
- 206010064571 Gene mutation Diseases 0.000 claims description 4
- 238000012098 association analyses Methods 0.000 claims description 3
- 238000003745 diagnosis Methods 0.000 abstract description 18
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000013473 artificial intelligence Methods 0.000 abstract description 5
- 238000012790 confirmation Methods 0.000 abstract 1
- 238000007405 data analysis Methods 0.000 description 4
- 230000002547 anomalous effect Effects 0.000 description 2
- 238000010219 correlation analysis Methods 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F18/00—Pattern recognition
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/12—Computing arrangements based on biological models using genetic models
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the invention belongs to the technical field of artificial intelligence, and relates to various types of medical data analysis technology, image intelligent recognition technology, optimization method and other technologies and methods.
- the diagnostic gain improves the genetic optimization method, and according to the diagnostic gain of the characteristic item described in S12 of claim 1, the genetic optimization method is used to judge the characteristic optimal characteristic group of the disease, intelligently identify the disease, and realize Diagnostic data performance is optimized.
- the purpose of the present invention is to provide an optimal method for disease analysis and identification of characterization, blood, and image data multi-data association fusion.
- the combination of artificial intelligence technology and various types of medical data correlation analysis technology and intelligent diagnosis improves the efficiency of data analysis and judgment and improves the rate of disease diagnosis.
- the main organ is associated with related organs, and the association rules of various types of medical data between organs are analyzed.
- an improved genetic method is used to optimize the identification probability of the feature items. Analyze various abnormal indicators, effectively identify medical images, intelligently manage medical data, realize the optimal combination of medical data diagnosis items and feature items, and improve the efficiency of analysis and diagnosis.
- the sum of the recognition probabilities of all feature items of each division method is taken as the total recognition probability of each division method
- diagnostic gain total identification probability of each division mode - initialization identification probability
- the objective function is to minimize the diagnostic gain
- the optimal calculation method obtains the optimal diagnosis data set of the disease according to the optimization method.
- identification probability sum calculation method of the feature item described in S8 is as follows:
- Step 1 To characterize each sample, extract its corresponding organ;
- Step2 Extract its organ image data, blood cell image data and blood data in the sample
- Step3 If it is a blood abnormal feature item, increase the count value of the feature item. Increase the count value of the total feature item;
- Step6 If the abnormal feature count value of the feature > the identification number of the corresponding feature item, set it as the hard identification probability,
- the abnormal feature count value of the feature ⁇ the corresponding identification number set it as the soft identification probability
- Step7 Return the recognition probability of the feature.
- identification probability of the characteristic item described in S12 is optimized to improve the genetic method as follows:
- Step1 Set each division method as a population
- Step2 Select the feature items of each division method as genes, and the total number of feature items as the number of genes;
- Step3 Variable setting, when the feature item is selected in this division method, the variable value of the selected locus is 1;
- variable value of the unselected locus is 0;
- Step4 Use to select the optimal population
- Step5 In the cross parent chromosomes A and B, the gene method of selecting two genes and exchanging loci is:
- Step6 Gene mutation. Select the locus with the smallest identification probability value and change 1 to 0;
- Step7 The objective function is to minimize the diagnostic gain.
- the invention solves the problems in the prior art, such as difficulty in data analysis and inaccurate data judgment, through multi-data fusion.
- a characterization, blood, image data multi-data correlation fusion disease analysis and diagnosis optimization method efficiently integrates multi-type data, multi-organ data, correlation analysis and comprehensive data, and realizes the optimal feature data set.
- FIG. 1 is a schematic flowchart of the multi-data fusion disease analysis and diagnosis optimization method in the specification of the present application.
- FIG. 2 is a schematic flow chart of the improved genetic method for optimizing the feature set in the specification of the present application.
- a characterization, blood, image data multi-data association fusion disease analysis and diagnosis optimization method steps method and its implementation method are taken as an example, but the implementation method is not limited to this.
- the step method of the embodiment is as follows:
- the identification probability corresponding to each feature item and the disease is calculated, the representation of the sample is calculated and extracted, and the corresponding organ is extracted. Its organ image data, blood cell image data and blood data in the sample. If there is a blood abnormal feature item, increase the count value of the feature item. Increment the count value of the total feature item. For each type of organ, for the blood cell image of each organ, if it is a blood cell abnormal feature item, increase the count value of the feature item. Increment the count value of the total feature item. For each type of organ, for each organ tissue image, if it is an abnormal feature item of the organ tissue, increase the count value of the feature item. Increment the count value of the total feature item.
- the abnormal feature count value of the feature > the identification number of the corresponding feature item, it is set as the hard identification probability. If the abnormal feature count value of the feature ⁇ the corresponding number of recognitions, it is set as the soft recognition probability. Returns the recognition probability for this feature.
- each division as a chromosome.
- the feature items of each division method are selected as genes, and the total number of feature items is used as the number of genes.
- the variable value of the unselected locus is 0. Use to select the optimal population.
- the gene method of selecting two genes and exchanging loci is as follows: "11" in a chromosome is exchanged with "01", "10" and "00” in another chromosome. The method of exchange is not limited to this.
- Gene mutation Select the locus with the smallest identification probability value and change 1 to 0. Enter the iteration and find the objective function to minimize the diagnostic gain.
- the parameters include; the population size ranges from 128 to 256.
- the crossover rate was between 0.01-0.75, the mutation rate was between 0.01-0.05, and the number of iterations was between 2000-5000.
Abstract
Description
Claims (3)
- 一种表征,血液,医疗图像数据多数据关联融合的疾病分析识别最优化方法,其特征在于融合多种类型数据,多特征数据,包括血液数据,各器官表征数据,血液细胞图像,器官组织医疗图像数据。多数据多器官相互关联,分析,计算最优的疾病智能识别增益作为目标函数的最优方法。步骤如下:A disease analysis and identification optimization method based on multi-data association and fusion of characterization, blood and medical image data, which is characterized by merging various types of data and multi-feature data, including blood data, each organ characterization data, blood cell images, and organ tissue medical treatment. image data. Multi-data and multi-organ correlation, analysis, and calculation of optimal disease intelligence recognition gain as the optimal method for the objective function. Proceed as follows:S1、创建主器官的疾病初始特征集合,初始化疾病智能识别概率;S1. Create a disease initial feature set of the main organ, and initialize the disease intelligent recognition probability;S2、创建主器官的关联器官对象列表;S2. Create a list of associated organ objects of the main organ;S3、抽取主器官的关联器官的特征项;S3. Extract the feature items of the associated organs of the main organ;S4、添加器官异常特征项添加到器官对象列表;S4. Add an abnormal feature item of an organ to the list of organ objects;S5、读取血液指标异常,筛选分析,添加异常特征项添加到特征候选列表;S5. Read abnormal blood indexes, screen and analyze, and add abnormal feature items to the feature candidate list;S6、表征器官及其他器官关联,数据关联分析,添加异常特征项添加到特征候选列表;S6. Characterize the association of organs and other organs, perform data association analysis, and add abnormal feature items to the feature candidate list;S7、读取其他器官血液细胞图像异常,其他器官组织图像异常;S7. The images of blood cells in other organs are abnormal, and the images of other organs and tissues are abnormal;添加异常特征项及值添加到特征候选列表;Add abnormal feature items and values to the feature candidate list;S8、创建最优特征组列表。抽取符合要求的元素放入最优特征组;S8. Create an optimal feature group list. Extract the elements that meet the requirements and put them into the optimal feature group;S9、遍历数据集中的所有特征项,随机抽取特征项作为划分方式,S9. Traverse all the feature items in the data set, and randomly extract the feature items as the division method,每种划分方式的所有特征项的疾病智能识别概率总和作为每种划分方式的疾病智能识别总概率,The sum of the probability of intelligent identification of diseases of all feature items of each division method is taken as the total probability of intelligent identification of diseases of each division mode,设置hard疾病智能识别概率及soft疾病智能识别概率的数值作为计算疾病智能识别总概率的参数;Set the values of hard disease intelligent recognition probability and soft disease intelligent recognition probability as parameters for calculating the total probability of disease intelligent recognition;S10、计算疾病智能识别增益,计算方法:疾病智能识别增益=各划分方式的疾病智能识别总概率-初始化疾病智能识别概率;S10. Calculate the intelligent disease identification gain, and the calculation method is as follows: the intelligent disease identification gain = the total probability of intelligent identification of diseases of each division method - the probability of intelligent identification of diseases initialized;S11、制约条件为:划分方式的疾病智能识别增益>固定疾病智能识别指数(固定疾病智能识别指数=1);S11. Constraints are: the disease intelligent identification gain of the division method > the fixed disease intelligent identification index (fixed disease intelligent identification index=1);S12、目标函数为疾病智能识别增益最小化;S12, the objective function is to minimize the gain of intelligent disease identification;S13、最优的计算方法依照最优化方法得到疾病的最优疾病智能识别数据组;S13, the optimal calculation method obtains the optimal disease intelligent identification data set of the disease according to the optimal method;
- 一种表征,血液,医疗图像数据多数据关联融合的疾病分析识别最优化方法,其特征在于,其包含一种特征项的疾病智能识别概率总和计算方法,对于每种疾病,计算各特征项与疾病对应的疾病智能识别概率步骤如下:A disease analysis and identification optimization method based on multi-data association and fusion of representation, blood and medical image data, characterized in that it includes a method for calculating the sum of the probability of intelligent identification of diseases of a characteristic item. The steps of intelligent recognition probability of disease corresponding to disease are as follows:Step1.对每个样本的表征,抽取其对应的器官;Step1. To characterize each sample, extract its corresponding organ;Step2.抽取其器官图像数据,血液细胞图像数据及其样本中的血液数据;Step2. Extract its organ image data, blood cell image data and blood data in the sample;Step3.如果为血液异常特征项,增加该特征项的计数值。增加总特征项的计数值;Step3. If it is a blood abnormal feature item, increase the count value of the feature item. Increase the count value of the total feature item;Step4.对每个类别的器官,对每个器官的血液细胞图像,Step4. For each type of organ, for the blood cell image of each organ,如果为血液细胞图像异常特征项,增加该特征项的计数值,If it is an abnormal feature item of blood cell image, increase the count value of this feature item,增加总特征项的计数值;Increase the count value of the total feature item;Step5.对每个类别的器官,Step5. For each type of organ,对每个器官组织图像,For each organ tissue image,如果为器官组织图像异常特征项,增加该特征项的计数值,If it is an abnormal feature item of the organ tissue image, increase the count value of the feature item,增加总特征项的计数值;Increase the count value of the total feature item;Step6.如果该特征的异常特征计数值>对应特征项的疾病智能识别数目,将其设定为hard疾病智能识别概率;Step6. If the abnormal feature count value of the feature > the number of intelligent identification of diseases of the corresponding feature item, set it as the probability of intelligent identification of hard diseases;如果,该特征的异常特征计数值<对应的疾病智能识别数目,将其设定为soft疾病智能识别概率;If, the abnormal feature count value of the feature is less than the corresponding number of intelligent identification of diseases, set it as the probability of intelligent intelligent identification of soft diseases;Step7.返回该特征的疾病智能识别概率。Step7. Return the disease intelligence recognition probability of the feature.
- 一种表征,血液,医疗图像数据多数据关联融合的疾病分析识别最优化方法,其特征在于,一种疾病智能识别增益最优化方法,利用最优化方法实现疾病智能识别,根据权利要求1的S12所述的特征项组合的改进遗传最优化方法如以下步骤:An optimization method for disease analysis and identification based on multi-data association and fusion of representation, blood and medical image data, characterized in that it is an optimization method for intelligent disease identification gain, and the optimization method is used to realize intelligent identification of diseases, according to S12 of claim 1 The improved genetic optimization method of the described feature item combination is as follows:Step1.设定每种划分方式作为染色体;Step1. Set each division method as chromosome;Step2.选定每种划分方式的特征项作为基因,特征项总数作为基因位数;Step2. Select the feature items of each division method as genes, and the total number of feature items as the number of genes;Step3.变量设定,当特征项被选取在此种划分方式里,被选取的基因位的变量值为1;Step3. Variable setting, when the feature item is selected in this division method, the variable value of the selected locus is 1;未被选取的基因位的变量值为0;The variable value of the unselected locus is 0;Step4.利用选择最优的染色体种群;Step4. Use to select the optimal chromosome population;Step5.交叉父母染色体A,B中,选择需要交换的基因位,并交换基因位的基因方法为:Step5. In the cross parent chromosomes A and B, select the locus that needs to be exchanged, and the gene method to exchange the locus is:染色体中的“11”与另一染色体中的“01”“10”“00”交换,交换的方法不限于此;"11" in a chromosome is exchanged with "01", "10" and "00" in another chromosome, and the method of exchange is not limited to this;Step6.基因突变,选择带有”1”的基因位作为基因突变位置,如疾病智能识别概率值最小,将1变为0;Step6. Gene mutation, select the locus with "1" as the gene mutation position. If the probability value of intelligent recognition of disease is the smallest, change 1 to 0;Step7.目标函数为疾病智能识别增益最小化。Step7. The objective function is to minimize the gain of intelligent disease identification.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021393938A AU2021393938A1 (en) | 2020-12-11 | 2021-12-08 | Method for optimization of disease analysis and identification by multi-data correlation fusion of characterization, blood, and medical image data |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011468328.8 | 2020-12-11 | ||
CN202011468328 | 2020-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022121063A1 true WO2022121063A1 (en) | 2022-06-16 |
Family
ID=81974013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/000232 WO2022121063A1 (en) | 2020-12-11 | 2021-12-08 | Method for optimization of disease analysis and identification by multi-data correlation fusion of characterization, blood, and medical image data |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2021393938A1 (en) |
WO (1) | WO2022121063A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115062242A (en) * | 2022-07-11 | 2022-09-16 | 广东加一信息技术有限公司 | Intelligent information identification method based on block chain and artificial intelligence and big data system |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102567308A (en) * | 2011-12-20 | 2012-07-11 | 上海电机学院 | Information processing feature extracting method |
JP2012238075A (en) * | 2011-05-10 | 2012-12-06 | Nippon Telegr & Teleph Corp <Ntt> | Feature selecting device, feature selecting method, and feature selecting program |
CN109117864A (en) * | 2018-07-13 | 2019-01-01 | 华南理工大学 | Coronary heart disease risk prediction technique, model and system based on heterogeneous characteristic fusion |
CN109480780A (en) * | 2018-11-14 | 2019-03-19 | 重庆三峡医药高等专科学校 | A kind of cerebral apoplexy early warning system and method |
CN111081381A (en) * | 2019-11-08 | 2020-04-28 | 李静 | Intelligent screening method for critical indexes of prediction of nosocomial fatal gastrointestinal rebleeding |
-
2021
- 2021-12-08 AU AU2021393938A patent/AU2021393938A1/en active Pending
- 2021-12-08 WO PCT/CN2021/000232 patent/WO2022121063A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012238075A (en) * | 2011-05-10 | 2012-12-06 | Nippon Telegr & Teleph Corp <Ntt> | Feature selecting device, feature selecting method, and feature selecting program |
CN102567308A (en) * | 2011-12-20 | 2012-07-11 | 上海电机学院 | Information processing feature extracting method |
CN109117864A (en) * | 2018-07-13 | 2019-01-01 | 华南理工大学 | Coronary heart disease risk prediction technique, model and system based on heterogeneous characteristic fusion |
CN109480780A (en) * | 2018-11-14 | 2019-03-19 | 重庆三峡医药高等专科学校 | A kind of cerebral apoplexy early warning system and method |
CN111081381A (en) * | 2019-11-08 | 2020-04-28 | 李静 | Intelligent screening method for critical indexes of prediction of nosocomial fatal gastrointestinal rebleeding |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115062242A (en) * | 2022-07-11 | 2022-09-16 | 广东加一信息技术有限公司 | Intelligent information identification method based on block chain and artificial intelligence and big data system |
Also Published As
Publication number | Publication date |
---|---|
AU2021393938A1 (en) | 2023-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112201330B (en) | Medical quality monitoring and evaluating method combining DRGs tool and Bayesian model | |
WO2022121063A1 (en) | Method for optimization of disease analysis and identification by multi-data correlation fusion of characterization, blood, and medical image data | |
CN113113130A (en) | Tumor individualized diagnosis and treatment scheme recommendation method | |
CN116741397B (en) | Cancer typing method, system and storage medium based on multi-group data fusion | |
Wang et al. | Diabetes Risk Analysis Based on Machine Learning LASSO Regression Model | |
CN114239404A (en) | Intelligent material optimization design method based on multi-objective optimization | |
CN115100467A (en) | Pathological full-slice image classification method based on nuclear attention network | |
CN113903458A (en) | Acute kidney injury early prediction method and device | |
Kumar et al. | Integrating Diverse Omics Data Using Graph Convolutional Networks: Advancing Comprehensive Analysis and Classification in Colorectal Cancer | |
CN116525114A (en) | Renal clear cell carcinoma prognosis prediction model based on PDK1 combined immunity | |
CN114821137A (en) | Multi-modal tumor data fusion method and device | |
JP2004355174A (en) | Data analysis method and system | |
Mythili et al. | CTCHABC-hybrid online sequential fuzzy Extreme Kernel learning method for detection of Breast Cancer with hierarchical Artificial Bee | |
Kumar et al. | An Early Cancer Prediction Based On Deep Neural Learning | |
Yazid et al. | Clinical pathway variance prediction using artificial neural network for acute decompensated heart failure clinical pathway | |
CN112466389A (en) | Method and system for obtaining tumor marker based on machine learning algorithm | |
Das et al. | Advanced Optimization Techniques & Its Application in AI-Powered Breast Cancer Classification | |
CN108280327B (en) | Ex-warehouse method for improving sample diversity of sample library | |
WO2022126799A1 (en) | Intelligent multi-data fusion disease-identifying method | |
US20240119314A1 (en) | Gene coding breeding prediction method and device based on graph clustering | |
CN113642660B (en) | Information gain characterization method for road surface multidimensional detection data | |
Begum et al. | A survey of feature selection methods for the analysis of microarrays data in cancer | |
CN117079821B (en) | Patient hospitalization event prediction method | |
CN115394435B (en) | Method and system for identifying key clinical index entity based on deep learning | |
CN109934139B (en) | Muscle electric signal channel combination optimization method based on group intelligent algorithm |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21901782 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2023540063 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021901782 Country of ref document: EP Effective date: 20230711 |
|
ENP | Entry into the national phase |
Ref document number: 2021393938 Country of ref document: AU Date of ref document: 20211208 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 21/09/2023) |